Expression of the stress-associated protein p8 is a requisite for tumor development

International Journal of Gastrointestinal Cancer

Volumn 31, Issue 1-3, 2002, Pages 89-98

  Iovanna, Juan L ^a  

^a INSERM   (France)

Author keywords

Cellular stress; Knockout mice; P8; Stress proteins; Tumor progression

Indexed keywords

GENE PRODUCT; HIGH MOBILITY GROUP PROTEIN; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN P8; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; FIBROBLAST; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; GENE STRUCTURE; MOUSE; NONHUMAN; NUDE MOUSE; PANCREATITIS; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; STRESS; TUMOR GROWTH;

EID: 0036940734     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:31:1-3:89     Document Type: Review

References (41)

1. Dusetti NJ, Tomasini R, Azizi A, et al. Expression profiling in pancreas during the acute phase of pancreatitis using cDNA microarrays. Biochem Biophys Res Commun 2000;277:660-667.
2. Mallo GV, Fiedler F, Calvo EL, et al. Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. J Biol Chem 1997;272:32,360-32,369.
3. Jiang YF, Vaccaro MI, Fiedler F, et al. Lipopolysaccharides induce p8 mRNA expression in vivo and in vitro. Biochem Biophys Res Commun 1999;260:686-690.
4. Garcia-Montero A, Vasseur S, Mallo GV, et al. Expression of the stress-induced p8 mRNA is transiently activated after culture medium change. Eur J Cell Biol 2001;80:720-725.
5. Vasseur S, Mallo GV, Fiedler F, et al. Cloning and expression of the human p8, a nuclear protein with mitogenic activity. Eur J Biochem 1999;259:670-675.
6. Vasseur S, Mallo GV, Garcia-Montero A, et al. Structural and functional characterization of the mouse p8 gene: promotion of transcription by the CAAT-enhancer binding protein alpha (C/EBPalpha) and C/EBPbeta trans-acting factors involves a C/EBP cis-acting element and other regions of the promoter. Biochem J 1999;343:377-383.
7. Igarashi T, Kuroda H, Takahashi S, et al. Cloning and characterization of the Xenopus laevis p8 gene. Develop Growth Differ 2001;43:693-698.
8. Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acids Res Mol Biol 1996;54:35-100.
9. Bergel M, Herrera JE, Thatcher BJ, et al. Acetylation of novel sites in the nucleosomal binding domain of chromosomal protein HMG-14 by p300 alters its interaction with nucleosomes. J Biol Chem 2000;275:11,514-11,520.
10. Encinar JA, Mallo GV, Mizyrycki C, et al. Human p8 is a HMGM-I/Y-like protein with DNA binding activity enhanced by phosphorylation. J Biol Chem 2001;276:2742-2751.
11. Croniger C, Leahy P, Reshef L, et al. C/EBP and the control of phosphoenolpyruvate carboxykinase gene transcription in the liver. J Biol Chem 1998;273:31,629-31,632.
12. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 1998;273:28,545-28,548.
13. Fidler IJ. Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst 1995;87:1588-1592.
14. Uhr JW, Scheuermann RH, Street NE, et al. Cancer dormancy: opportunities for new therapeutic approaches. Nat Med 1997;3:505-509.
15. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149-153.
16. Luzzi KJ, MacDonald IC, Schmidt EE, et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998;153:865-873.
17. Kerbel RS: Significance of tumor-host interactions in cancer growth and metastases. Cancer Metastasis Rev 1995;14:259-262.
18. Su SB, Motoo Y, Iovanna JL, et al. Expression of p8 in human pancreatic cancer. Clin Cancer Res 2001;7:309-313.
19. Su SB, Motoo Y, Iovanna JL, et al. Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer. Clin Cancer Res 2001;7:1320-1324.
20. Ree AH, Pacheco MM, Tvermyr M, et al. Expression of a novel factor, com1, in early tumor progression of breast cancer. Clin Cancer Res 2000;6:1778-1783.
21. Ree AH, Tvermyr M, Engebraaten O, et al. Expression of a novel factor in human breast cancer cells with metastatic potential. Cancer Res 1999;59:4675-4680.
22. Vasseur S, Hoffmeister A, Garcia S, et al. p8 is critical for tumor development induced by rasV12 mutated protein and E1A oncogene. EMBO Rep 2002;3:165-170.
23. Garcia-Montero AC, Vasseur S, Giono LE, et al. Transforming growth factor beta-1 enhances Smad transcriptional activity through activation of p8 gene expression. Biochem J 2001;357:249-253.
24. Himes SR, Reeves R, Attema J, et al. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation. J Immunol 2000;164:3157-3168.
25. Bonnefoy E, Bandu MT, Doly J. Specific binding of high-mobility-group I (HMGI) protein and histone H1 to the upstream AT-rich region of the murine beta interferon promoter: HMGI protein acts as a potential antirepressor of the promoter. Mol Cell Biol 1999;19:2803-2816.
26. Mantovani F, Covaceuszach S, Rustighi A, et al. NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C. Nucleic Acids Res 1998;26:1433-1439.
27. Arlotta P, Rustighi A, Mantovani F, et al. High mobility group I proteins interfere with the homeodomains binding to DNA. J Biol Chem 1997;272:29,904-29,910.
28. Wood LD, Farmer AA, Richmond A. HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene. Nucleic Acids Res 1995;23:4210-4219.
29. Utz PJ, Anderson P. Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules. Cell Death Differ 2000;7:589-602.
30. Wang E, Marcotte R, Petroulakis E. Signaling pathway for apoptosis: a racetrack for life or death. J Cell Biochem 1999;32-33:95-102.
31. Vasseur S, Hoffmeister A, Garcia-Montero A, et al. p8-deficient fibroblasts growth more rapidly and are more resistant to the apoptosis induced by adriamycin. Oncogene 2002;21:1685-1694.
32. Amundson SA, Myers TG, Fornace AJ. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 1998;17:3287-3299.
33. Colman MS, Afshari CA, Barrett JC. Regulation of p53 stability and activity in response to genotoxic stress. Mutat Res 2000;462:179-188.
34. Farmer G, Colgan J, Nakatani Y, et al. Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo. Mol Cell Biol 1996;16:4295-4304.
35. Martin DW, Munoz RM, Subler MA, et al. p53 binds to the TATA-binding protein-TATA complex. J Biol Chem 1993;268:13,062-13,067.
36. Ragimov N, Krauskopf A, Navot N, et al. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene 1993;8:1183-1193.
37. Seto E, Usheva A, Zambetti GP, et al. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 1992;89:12,028-12,032.
38. Serrano M, Lin AW, McCurrach ME, et al. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p161NK4a. Cell 1997;88:593-602.
39. Lin AW, Barradas M, Stone JC, et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998;12:3008-3019.
40. Vousden KH: p53: death star. Cell 2000;103:691-694.
41. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-310.